163 related articles for article (PubMed ID: 15717632)
41. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
42. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
Lorenzo V; Martin-Malo A; Perez-Garcia R; Torregrosa JV; Vega N; de Francisco AL; Cases A
Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
[TBL] [Abstract][Full Text] [Related]
43. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
44. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
45. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
46. Beta2-microglobulin.
Drüeke TB; Massy ZA
Semin Dial; 2009; 22(4):378-80. PubMed ID: 19708985
[TBL] [Abstract][Full Text] [Related]
47. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
Leypoldt JK
Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
[TBL] [Abstract][Full Text] [Related]
48. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
[TBL] [Abstract][Full Text] [Related]
49. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
50. What is good about PD + HD combined therapy.
Yamashita AC; Tomisawa N
Hemodial Int; 2011 Oct; 15 Suppl 1():S15-21. PubMed ID: 22093595
[TBL] [Abstract][Full Text] [Related]
51. Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
Krieter DH; Hunn E; Morgenroth A; Lemke HD; Wanner C
Artif Organs; 2008 Dec; 32(12):903-9. PubMed ID: 19133017
[TBL] [Abstract][Full Text] [Related]
52. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
53. Effects of high-flux hemodialysis on plasma adrenomedullin and sustained hypotension in elderly hemodialysis patients.
Zhang D; Sun XF; Ma ZF; Zhu HY; Wang YD; Chen XM
Chin Med J (Engl); 2011 Mar; 124(6):907-10. PubMed ID: 21518601
[TBL] [Abstract][Full Text] [Related]
54. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.
Korabecna M; Opatrna S; Wirth J; Rulcova K; Eiselt J; Sefrna F; Horinek A
Ann N Y Acad Sci; 2008 Aug; 1137():296-301. PubMed ID: 18837963
[TBL] [Abstract][Full Text] [Related]
55. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
56. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
Schiffl H
Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
[TBL] [Abstract][Full Text] [Related]
57. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
[TBL] [Abstract][Full Text] [Related]
58. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients.
Schiffl H
Hemodial Int; 2014 Jan; 18(1):136-41. PubMed ID: 23718290
[TBL] [Abstract][Full Text] [Related]
59. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
60. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
